Charles S. Berkman, VP, General Counsel & Secretary at LIGAND PHARMACEUTICALS INC (LGND), sold 14,067 shares at $99.86 ($1.4M) on 2015-07-10, disclosed to the SEC on 2015-07-14.
Scheduled sale ($1.4M) by VP, General Counsel & Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.15 | 2,404 | $236K | 16.9% |
| 2 | $99.18 | 8,838 | $877K | 62.9% |
| 3 | $99.86 | 2,825 | $282K | 20.2% |
| Total | $99.14 avg | 14,067 | $1.4M | 100% |
| Filing → |
| OABI | SELL | 2026-02-17 | $12K | — | Filing → |
| OABI | SELL | 2025-12-09 | $16K | — | Filing → |
| OABI | SELL | 2025-04-07 | $14K | — | Filing → |